$RGNX stock has now fallen 40% today, according to our price data from Polygon. There has been approximately $30,636,116 of trading volume.
It has been the 263rd most-searched ticker on Quiver Quantitative over the last day, out of 13,195 total tickers searched.
Here is what we see in our data on $RGNX (you can track the company live on Quiver's $RGNX stock page):
$RGNX Insider Trading Activity
$RGNX insiders have traded $RGNX stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $RGNX stock by insiders over the last 6 months:
- STEVE PAKOLA (Chief Medical Officer) has made 0 purchases and 2 sales selling 20,433 shares for an estimated $221,738.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$RGNX Hedge Fund Activity
We have seen 80 institutional investors add shares of $RGNX stock to their portfolio, and 85 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO removed 483,746 shares (-12.0%) from their portfolio in Q4 2025, for an estimated $6,965,942
- INVENOMIC CAPITAL MANAGEMENT LP removed 426,904 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6,147,417
- ACADIAN ASSET MANAGEMENT LLC removed 372,166 shares (-99.1%) from their portfolio in Q1 2026, for an estimated $3,118,751
- REDMILE GROUP, LLC removed 324,585 shares (-6.9%) from their portfolio in Q4 2025, for an estimated $4,674,024
- MORGAN STANLEY added 310,520 shares (+18.2%) to their portfolio in Q4 2025, for an estimated $4,471,488
- STATE STREET CORP added 301,858 shares (+15.2%) to their portfolio in Q4 2025, for an estimated $4,346,755
- VOSS CAPITAL, LP removed 280,000 shares (-48.7%) from their portfolio in Q4 2025, for an estimated $4,032,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$RGNX Analyst Ratings
Wall Street analysts have issued reports on $RGNX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 12/19/2025
- Chardan Capital issued a "Buy" rating on 11/20/2025
To track analyst ratings and price targets for $RGNX, check out Quiver Quantitative's $RGNX forecast page.
$RGNX Price Targets
Multiple analysts have issued price targets for $RGNX recently. We have seen 6 analysts offer price targets for $RGNX in the last 6 months, with a median target of $25.0.
Here are some recent targets:
- Yi Chen from HC Wainwright & Co. set a target price of $30.0 on 03/09/2026
- Judah Frommer from Morgan Stanley set a target price of $17.0 on 03/06/2026
- Daniil Gataulin from Chardan Capital set a target price of $50.0 on 02/10/2026
- Paul Choi from Goldman Sachs set a target price of $12.0 on 02/10/2026
- Annabel Samimy from Stifel set a target price of $45.0 on 12/19/2025
- Mani Foroohar from Leerink Partners set a target price of $20.0 on 12/15/2025
You can track data on $RGNX on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
